Sle-Das Enables an Accurate Definition of Severe Lupus Disease Activity: Derivation and Validation in a Post Hoc Study of Anifrolumab Phase Ii and Iii Studies
                        AuthID
P-018-RT5
                
    P-018-RT5
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service